Form 4: Upstart CEO Exercises Options, Sells Shares
Insider Transaction Report
Upstart Holdings CEO Dave Girouard exercised stock options and subsequently sold an equivalent number of shares totaling 41,667, pursuant to a Rule 10b5-1 trading plan.
Summary
- Dave Girouard, Chief Executive Officer, Director, and 10% Owner of Upstart Holdings, Inc. (UPST), reported transactions on September 15, 2025.
- He exercised employee stock options to acquire 41,667 shares of Common Stock at an exercise price of $0.83 per share.
- Concurrently, he sold a total of 41,667 shares of Common Stock in two separate transactions.
- The first sale involved 34,825 shares at a weighted average price of $64.838 per share, with prices ranging from $64.35 to $65.345.
- The second sale involved 6,842 shares at a weighted average price of $65.4139 per share, with prices ranging from $65.35 to $65.59.
- All reported transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.
- Following these transactions, Mr. Girouard directly holds 52,614 shares of Common Stock and indirectly holds 10,687,817 shares through various trusts.
- He also retains 835,075 unexercised employee stock options with an exercise price of $0.83, which are fully vested and exercisable, and expire on September 20, 2026.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing reports a pre-planned, non-discretionary transaction by an insider under a Rule 10b5-1 plan. This type of transaction is common for executives to manage their personal finances and equity compensation and does not inherently signal a positive or negative outlook on the company's future performance.
Positives
- The executive realized a significant gain by exercising options at $0.83 and selling shares at an average price of approximately $65, demonstrating successful monetization of equity compensation.
- The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a non-discretionary sale and potentially reducing concerns about opportunistic insider trading.
- The net change in direct beneficial ownership from these specific transactions is zero, as the number of shares acquired through option exercise precisely matched the number of shares sold.
Negatives
- The sale of shares by a key executive, even if pre-planned, could be interpreted by some investors as a signal of reduced confidence in the company's near-term growth prospects, although this is mitigated by the 10b5-1 plan.
Future Outlook
The filing does not provide any forward-looking statements or guidance regarding the company's future performance. It solely reports past insider transactions.
Industry Context
This filing reports a routine insider transaction, common across publicly traded companies where executives receive equity compensation. It does not provide information to analyze broader industry trends or competitor performance.
Comparison to Industry Standards
- The exercise of stock options and subsequent sale of shares is a standard practice for executives to monetize their equity compensation and manage personal finances.
- The use of a Rule 10b5-1 plan aligns with best practices for insider trading compliance, demonstrating a pre-planned, non-discretionary approach to transactions, which is a common and accepted method for insiders to trade company stock.
Related Party Transactions
- Dave Girouard's indirect beneficial ownership includes shares held by various trusts (2008 D&T Girouard Revocable Trust, DTG GRAT LLC, TMG 2020 EXEMPT GIFT TRUST, JRG 2020 EXEMPT GIFT TRUST, TMG 2020 NONEXEMPT GIFT TRUST, JRG 2020 NONEXEMPT GIFT TRUST), for which he or a related party serves as trustee. These are standard arrangements for executive wealth management and are disclosed as indirect beneficial ownership.
Stakeholder Impact
- Shareholders: May view the sale as a routine diversification or monetization of equity compensation, especially given the 10b5-1 plan. Some might interpret it as a slight negative signal, though the pre-planned nature mitigates this.
Next Steps
- The remaining 835,075 employee stock options held by Dave Girouard will expire on September 20, 2026, if not exercised before then.
Key Dates
| Date | Description |
|---|---|
| 08/29/2024 | Rule 10b5-1 trading plan adopted by Dave Girouard. |
| 09/15/2025 | Date of option exercise and subsequent share sales. |
| 09/17/2025 | Date the Form 4 filing was signed. |
| 09/20/2026 | Expiration date of remaining employee stock options. |
Recommendation
holdThe filing details a pre-planned insider transaction (option exercise and subsequent sale) by the CEO, executed under a Rule 10b5-1 trading plan. Such routine transactions are generally not indicative of a change in the company's fundamental outlook or a signal for investors to alter their positions based solely on this filing. The transaction represents a monetization of vested equity compensation rather than a discretionary sale based on new material information.
Keywords
Upstart Holdings, UPST, Dave Girouard, Insider Trading, Form 4, Stock Option Exercise, Share Sale, 10b5-1 Plan, CEO, Director, 10% Owner, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.